GSK CEO Witty Still Not Interested In A Consumer Spinoff…For Now

With a diverse business portfolio and some enterprising competitors, GlaxoSmithKline (GSK) has been the subject of spinoff rumors for years. So far, the company has opted to not pursue any divestitures of that nature and that will remain the case for some time if CEO Andrew Witty has his way. Well…at least regarding the consumer unit. While discussing the… Read More »